is tirzepatide on the shortage list Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says Lilly (LLY) CEO Says Weight-Loss

doi: 10.1053/j.gastro.2004.04.063 35 PocaiA

When that family member is on GLP-1s, what comes into the house is different

He said lowering prices is our investment for the future and for capturing more patients. More than 1 million people used Lillys direct-to-consumer platform, LillyDirect, in 2025, and self-pay Zepbound vials now account for roughly a third of new obesity drug prescriptions in the US, Lilly CEO Dave Ricks told analysts

Various inflammatory factors can trigger the phosphorylation and degradation of IB and translocate NF-B into the nucleus, facilitating inflammatory protein synthesis and pro-inflammatory molecule release (IL-6, TNF-), leading to cartilage degeneration 48,49,50

And convenience changes adoption